Our commitment to every patient
At Alexion, we believe that progress in medicine begins with partnership and trust. Every clinical trial we conduct reflects our commitment to equity, transparency, and patient safety. Our goal is to make clinical research accessible, inclusive, and reflective of the real-world communities we aim to serve, so every patient can see themselves represented in the science shaping the future of care.
Research that includes everyone
Diversity, equity, and inclusion
Alexion is committed to designing clinical programs with equity at the forefront. We are dedicated to continuing to work to improve participant diversity in clinical trials to mirror the real-world disease population. Our goal is to shape clinical trial diversity policies of the future while delivering for patients today.
Diversity in action
Inclusion is at the heart of every clinical trial. We partner with investigators, community organizations, and patient advocacy groups to reach underrepresented populations, prioritize diverse clinical trial sites, and provide clear, accessible materials. By building equity into every step, we ensure research reflects the real-world communities it aims to serve.
50+ countries represented across Alexion’s research programs, reflecting our global focus on rare disease.
Every trial is designed with inclusion in mind, ensuring diversity and equity goals are built in from the start.
Strong partnerships with patient communities, working hand in hand with advocacy groups to shape trial design and outreach.
Rigorous safety and ethical standards guiding every clinical trial, protecting participants’ well-being and data at every step.
Our commitment to safety in clinical trials
-
Protecting your privacy
Protecting patient data is essential to how we build and maintain trust. All personal and health information collected in Alexion trials is handled under strict confidentiality standards. Data is securely stored, anonymized, and used only for approved research purposes. We comply with global privacy regulations, including the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), to ensure participants’ rights and safety remain our highest priority.
-
Keeping your biosamples safe
At Alexion, we prioritize the ethical collection and use of biosamples, such as blood, urine, and saliva, to advance research in rare diseases. These samples are invaluable in understanding disease mechanisms and developing targeted therapies. We adhere to strict ethical guidelines and obtain informed consent from all participants, ensuring transparency and respect for their contributions. Each biosample is handled with the utmost care, maintaining confidentiality and integrity throughout the research process.
What happens to your biosamples
